Outset Medical (OM) Total Debt Growth (1y) (2020 - 2026)
Outset Medical (OM) Total Debt Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.59 Bn | 176.29 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 129.07 Bn | 126.19 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 108.58 Bn | 99.36 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 68.64 Bn | 67.19 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 48.38 Bn | 44.71 Bn | 1.29 Bn | 0.12% |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.13 Bn | 25.84 Bn | 1.98 Bn | -5.76% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | -2.49% |
| 9 | Koninklijke Philips | 24.27 Bn | 21.15 Bn | 2.07 Bn | 19.06% |
| 10 | Outset Medical | 80,014.42 | -286.56 Mn | 12.10 Mn | 3.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00% |
| Dec 31, 2025 | -51.24% |
| Sep 30, 2025 | -51.56% |
| Jun 30, 2025 | -51.87% |
| Mar 31, 2025 | -52.18% |
| Dec 31, 2024 | 51.70% |
| Sep 30, 2024 | 103.73% |
| Jun 30, 2024 | 103.87% |
| Mar 31, 2024 | 103.99% |
| Dec 31, 2023 | 35.06% |
| Sep 30, 2023 | 224.47% |
| Jun 30, 2023 | 213.67% |
| Mar 31, 2023 | 223.93% |
| Dec 31, 2022 | 223.69% |
| Sep 30, 2022 | 0.30% |
| Jun 30, 2022 | 3.66% |
| Mar 31, 2022 | 0.30% |
| Dec 31, 2021 | 0.30% |
| Sep 30, 2021 | 0.30% |
| Dec 31, 2020 | 2.11% |